BioNTech SE Working Capital Growth & History (BNTX)

BioNTech SE's working capital was €14.00B for fiscal 2025.

View full BioNTech SE company overview

BioNTech SE annual working capital history

BioNTech SE annual working capital

Fiscal yearPeriod endedWorking capitalChangeGrowth
20252025-12-31€14.00B−€2.28B−13.98%
20242024-12-31€16.28B−€1.18B−6.74%
20232023-12-31€17.46B−€1.51B−7.98%
20222022-12-31€18.97B€7.38B+63.68%
20212021-12-31€11.59B€10.53B+992.53%
20202020-12-31€1.06B€638.9M+151.39%
20192019-12-31€422.0M€99.2M+30.72%
20182018-12-31€322.8M

BioNTech SE working capital trends

Over the last five fiscal years, BioNTech SE's working capital increased from €1.06B to €14.00B, a change of €12.94B. The latest reported quarter, Q2 2026, shows €13.35B.

About the metric

What working capital means

Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.

Calculation and source

How working capital is calculated

TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioNTech SE source filings ↗

Community posts

It’s quiet here.

No posts about BNTX yet. Start the conversation.

Write the first post